PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Themes

Antibiotics and Ribosome Function

PSI-SGKB [doi:10.3942/psi_sgkb/fm_2010_3]
Featured System - March 2010
Short description: Antibiotics are often discovered in nature, where they are lethal weapons in the fight between different organisms.

Antibiotics are often discovered in nature, where they are lethal weapons in the fight between different organisms. The aminoglycoside antibiotics, such as streptomycin, are made by some bacteria to protect themselves from competing bacteria. They are particularly effective because they are specific: they attack bacterial ribosomes, corrupting protein synthesis in the bacterium, but they don't attack the ribosomes of many other organisms, such as our own ribosomes. This makes them perfect for use as antibiotic drugs--they will control a bacterial infection but have few side effects on our own cells.

Magic Bullets

As is often the case, streptomycin and other aminoglycoside antibiotics were discovered through their ability to kill bacteria, and then scientists had to figure out how they worked. These antibiotics have several effects on bacterial protein synthesis. They effect the way that messenger RNA is read, causing errors in translation and inhibiting the orderly stepping of the ribosome along the mRNA strand. They also cause problems at the end of protein synthesis, blocking the recycling of ribosomes after they are finished making a protein. A series of new structures, solved in collaboration with researchers at CSMP, have revealed the atomic basis of both of these effects.

Antibiotic Action

Structures of whole ribosomes with the antibiotic drugs neomycin, gentamycin and paromomycin have shown that there are two different binding sites. One site is in the small ribosomal subunit. The drug wedges into one of the ribosomal RNA helices at the site where the mRNA is matched with the appropriate tRNA, blocking the subtle motions needed for decoding and translocation. The second site is on the large ribosomal subunit, binding to a small loop of ribosomal RNA that interacts with ribosomal recycling factor (RRF), the protein that assists the recycling of ribosomes.

How to Stop Recycling

The structure shown here (PDB entry 2qbi) shows the complex of a ribosome (blue) with RRF (yellow) and the antibiotic drug neomycin (red). The small subunit of the ribosome has been removed to show the interaction, which is normally buried deep inside the intact ribosome. RRF interacts with a small loop in the ribosome, which is important in the interaction between the large and small subunits. By comparing this structure with a similar structure of the ribosome and RRF without the drug (PDB entry 2qbe), researchers have discovered that the antibiotic distorts the structure of this loop, freezing the motions that are necessary for recycling. To take a closer look at the interaction between the loop, RRF and the antibiotic, click on the image below for an interactive Jmol.

The JSmol tab below displays an interactive JSmol

Mre11 Nuclease (PDB entries 2q8u and 1ii7)

You can flip between two structures of Mre11 nuclease using the buttons below. The Thermatoga structure includes only the protein, which is composed of two domains--the nuclease domain colored light blue and the DNA-binding domain colored light green. The Pyrococcus structure has two metal ions (magenta) and a nucleotide (yellow) bound in the active site. The active site includes a histidine (red) that is important in the nuclease reaction, and several other amino acids (in pink) that coordinate


  1. Borovinshaya, M. A., Pai, R. D., Zhang, W., Schuwirth, B. S., Holton, J. M., Hirokawa, G., Kaji, H., Kaji, A. & Doudna Cate, J. H. (2007) Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nature Structural and Molecular Biology 14, 727-732.

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health